Processing

Please wait...

Settings

Settings

Goto Application

1. WO2018146257 - HEPATITIS E VIRUS VACCINE

Publication Number WO/2018/146257
Publication Date 16.08.2018
International Application No. PCT/EP2018/053291
International Filing Date 09.02.2018
IPC
C07K 14/335 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
195from bacteria
335from Lactobacillus (G)
CPC
A61K 2039/53
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
51comprising whole cells, viruses or DNA/RNA
53DNA (RNA) vaccination
A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
C07K 14/335
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
195from bacteria
335from Lactobacillus (G)
C12N 2770/28034
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
28011Hepeviridae
28034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N 2770/28134
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
28011Hepeviridae
28111Hepevirus, e.g. hepatitis E virus
28134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applicants
  • CLAYTON, Reginald [GB]/[GB]
  • GRETZ, Peter [AT]/[AT]
  • HABEL, André [DE]/[DE]
Inventors
  • CLAYTON, Reginald
  • GRETZ, Peter
  • HABEL, André
Agents
  • BEHRENS, Lüder
Priority Data
1702193.210.02.2017GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) HEPATITIS E VIRUS VACCINE
(FR) VACCIN CONTRE LE VIRUS DE L'HÉPATITE E
Abstract
(EN)
The present invention relates to a new HEV-specific vaccines as well as to methods of producing such vaccines, immunogenic polypeptides and nucleic acids encoding the same, and uses thereof in the treatment of and/or prevention from HEV infections.
(FR)
La présente invention concerne de nouveaux vaccins spécifiques du HEV ainsi que des procédés de production de tels vaccins, des polypeptides immunogènes et des acides nucléiques codant pour ceux-ci, et leurs utilisations dans le traitement et/ou la prévention d'infections par le VHE.
Latest bibliographic data on file with the International Bureau